Velsipity - Drug Details
๐Ÿ“Š Estimates Velsipity Dialyzability By Different_Modalities

Velsipity

Complete Drug Information

Drug Name
Velsipity
Trade Names
Velsipity
Pregnancy Category
AU: D
Routes of Administration
Oral
Protein Binding
97.90%%
Metabolism
Liver (CYP2C8, 2C9, 3A4)
Elimination
30 hours
Excretion
Feces (82%), kidneys (5%)
Formula
C26H26F3NO3
Molar Mass
457.493
Drug Class
Sphingosine-1-phosphate receptor modulator
Volume of Distribution
C26H26F3NO3

๐Ÿคฐ Pregnancy Category Information

Category: AU: D

Drugs which have caused, are suspected to have caused, or may be expected to cause an increased incidence of human fetal malformations or irreversible damage. These drugs may also have adverse pharmacological effects.